You searched for "treatment"
The European TINNET COST Action BM1306
Winfried Schlee describes how a major European funding award is bringing together experts who are committed to collectively developing a better understanding of tinnitus. This work is vital if we are to pioneer effective treatments for the condition in its...The James Lind Alliance – involving patients and their health professionals jointly in setting priorities for research
In a world of patient-reported outcomes and patient-centred care, patient-centred research must also be considered. That is where the James Lind Alliance (JLA) comes in, as Caroline Whiting explains below. Through Priority Setting Partnerships (PSPs), it allows patients, their carers...
How best to follow up a sinonasal cancer?
Sinonasal malignancies are rare tumours and, in the UK, are usually treated in tertiary treatment centres but may well be followed up long term in the patient’s local hospital, so advice on how best to manage these patients is invaluable....Fibre-delivered transoral laser surgery – description of a novel technique
Transoral flexible laser surgery refers to the use of a fibre-delivered laser for laryngeal procedures via direct laryngoscopy. We hear of a novel innovation. The continuous development of instruments to perform endoscopic procedures for treatment of laryngotracheal pathology – among...Lyric 24/7 hearing: could it help those with tinnitus?
About Lyric Hearing Since its launch in 2008, Lyric represents the first and only device of its kind establishing a new category of hearing solution: 24/7 extended wear. Lyric is placed several millimetres within the ear canal, near the tympanic...15th Congress of the European Skull Base Society
Whether you want to have an in-depth discussion on diagnostic issues and specific surgical treatments or a more general update on the background of skull base pathology, this meeting will serve your needs. One of the key features of the...
Long-term results for dupilumab are very promising!
Eosinophilic chronic rhinosinusitis (eCRS) is complicated by frequent early and aggressive recurrence of polyps after both medical and surgical treatment regimes. Dupilumab is an anti-IL-4/IL-3 receptor monoclonal antibody and has been previously studied in the SINUS-52 study, with an observation...Current perspectives of tinnitus and its management
Whilst there are various therapeutic options for ameliorating the impact of tinnitus, there is no current approved treatment for attempting to eradicate, or even for reducing, the loudness of tinnitus.
